So-Young International Inc. Regains Nasdaq Compliance with Minimum Bid Price Requirement

Reuters
Jul 03, 2025
So-Young International Inc. Regains Nasdaq Compliance with Minimum Bid Price Requirement

So-Young International Inc., a leading aesthetic treatment platform in China, has announced that it has regained compliance with the Nasdaq minimum bid price requirement. The company received a notification from Nasdaq confirming that it met the minimum bid price of $1.00 per share, as required by Nasdaq Listing Rule 5450(a)(1). Previously, So-Young had been notified on August 28, 2024, that it was not in compliance, as its share price had fallen below the threshold for 30 consecutive business days. The company was given until February 24, 2025, to rectify the situation, and upon failing to do so, was granted an additional 180-day extension. As of July 2, 2025, Nasdaq confirmed So-Young's compliance, marking the close of this regulatory issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. So-Young International Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN23611) on July 03, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10